Black Rose Industries Ltd Q2 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/4f6xcose5efq9g6b6x50cp4u.pdf

Key Takeaways


Volume vs. Value: The Quarter's Divergence

Daga: "we really don't study the capacity utilization with much significance while we try to, you know, improve our overall sales volumes and profitability. So, that is how we benchmark our performance and not to that extent the capacity utilization, because this additional capacity comes, you know, at a very, very, very low CapEx."

Manufacturing Margin Recovery


NMA: The New Revenue Stream


Product Pipeline & Expansion

Daga: "until now China was the only producer for Acrylamide solids and now we are the only alternate to China, so we have good acceptance of our product in terms of quality as well as availability and with that better price realization, we are concentrating on expanding our export business for the Acrylamide solids."

Market Position & Competitive Dynamics


Segment Outlook

Daga: "the product is not very highly concentrated, so that is one drawback and it is not a very, you know, high priced item, so the logistics cost would normally make it quite difficult to export the liquid form. However, you know once we start producing the polyacrylamide solid, we would be able to have good export volumes for that product."

Guidance & Commitments

CommitmentSpecificsTimeline
Polyacrylamide solids commercial launchCommercial production to beginQ3 FY25
NMA repeat ordersRepeat orders from large domestic and US customers expected to significantly improve salesCurrent quarter and coming quarters
Turkish REACH registrationRegistration finalised, supporting European market accessEnd of calendar year
Specialty chemicals JV with Japanese principalFormal agreement for project at Jhagadia plantFY25
R&D buildingBuilding in placeNext year
Export recovery (merchant)Subdued US oil and gas export volumes to improveNext financial year
Distribution/manufacturing revenue mixRatio to move closer to 50%Future quarters

Key Metrics

MetricQ2 FY24
Revenue+2% QoQ; volumes up more than 30% QoQ offset by lower chemical prices
Standalone EBITDA growth48%
EBITDA vs Q2 FY23~2.5x; Q2 FY23 EBITDA was about 5.34%
EBITDA vs Q1 FY24+50% QoQ
EPS (previous quarter)1.18
Return on equity and ROCE+50% YoY
Long-term debtZero
Distribution margins+20% QoQ
Distribution EBITDA vs Q2 FY23~2x
Manufacturing revenue+5%; lower price realisations offset by volume growth
Manufacturing volume growth~15%
Distribution volume growth~50%
Chemical distribution revenue share~2/3rd of total revenue
Export revenue share~1/3rd; down from 45% in Q1 FY24 due to reduced merchant exports
Top 5 products revenue share75% of topline
Top 5 products profit share72% of profit
Acrylonitrile price range$950/ton at quarter start, settling at $1,150–$1,200/ton by quarter end
Acrylamide liquid capacity32,000 MTPA; 20,000 MT for merchant sales, balance captive
Polyacrylamide liquid capacity40,000 MTPA
N-methylol Acrylamide capacity2,000 MT
Acrylamide solid capacity3,600 MT
Polyacrylamide solids commercial launch targetQ3 FY25
Morbi share of India ceramic tile manufacturing~80%